Oral antibiotics are noninferior after appendectomy for complicated appendicitis; digital follow-up tied to fewer readmissions

Listen to this post
read by AI voices · all episodesA three-day oral antibiotic course was noninferior to intravenous antibiotics for preventing abscess after laparoscopic appendectomy for complicated appendicitis in a 1,021-patient Danish trial published Nov. 13 in the British Journal of Surgery. A meta-analysis tied postoperative digital health follow-up to fewer readmissions, mainly when clinicians reviewed the data, and a 3,162-patient cohort linked primary tumor biology to survival after colorectal liver metastasis resection.
- Research Nov 13, 2026In a cluster-randomized, cluster-crossover trial at 12 Danish hospitals, published in the British Journal of Surgery, 1,021 adults with complicated appendicitis received a three-day oral or intravenous antibiotic course after laparoscopic appendectomy. Weighted 30-day intra-abdominal abscess rates, the primary end point, were 6.8% with oral and 4.9% with intravenous antibiotics in the intention-to-treat analysis (absolute risk difference 1.9%, 90% CI -0.4 to 4.2), meeting the noninferiority margin of 5 percentage points. Oral antibiotics shortened hospital stay by 41.1 hours but increased readmission (difference 4.7%, 95% CI 0.5 to 8.9).
- Technology Nov 10, 2026A systematic review and meta-analysis in Anesthesiology pooled 38 studies (30 randomized) with 7,494 adults after non-cardiac surgery. Digital health interventions were associated with fewer readmissions (risk ratio 0.85, 95% CI 0.73 to 0.99), but not with fewer all-cause complications (risk ratio 0.92, 95% CI 0.79 to 1.08). The readmission association held where a clinician reviewed patient-submitted data and could act (risk ratio 0.76, 95% CI 0.64 to 0.92), not where none did (risk ratio 0.96, 95% CI 0.78 to 1.18). The authors rated certainty of evidence low to very low.Sources: Anesthesiology, PubMed
- Research Nov 13, 2026An international cohort study in Annals of Surgery analyzed 3,162 patients from 44 centers who had liver resection for colorectal liver metastases between 2017 and 2023; 2,415 (76.4%) had recurrence and 1,342 (42.4%) died. Compared with left-sided wild-type tumors, mortality risk was highest with BRAF-mutant disease (hazard ratio 2.68, 95% CI 2.02 to 3.57) and right-sided RAS-mutant disease (hazard ratio 2.32, 95% CI 1.94 to 2.79). The authors said combining primary tumor site with RAS/BRAF status may support preoperative counseling, surveillance planning and trial stratification.Sources: Annals of Surgery, PubMed
The weekly innovation roundup for general surgery, published every Sunday for the week before; every item links to its sources. Latest general surgery news · All specialties